At CME we are incredibly proud of how our industry is rallying to do its part in the fight against COVID-19. Manufacturers around the country are reaching out to CME and to government to see how their resources and expertise can help our country, and our medical system in particular, in this time of crisis.

Although there is strong interest in industry to provide support, government is still trying to quantify what they need, who is qualified to make it and how such repurposing will be funded and applied. The challenge is amplified because some of the equipment is so complicated that it simply is far more practical to provide added support to the companies already making that equipment than to retool unrelated facilities.

As a proactive measure, CME wants to catalogue companies interested in supporting our nation at this time. We are collecting the names and capabilities of companies in the following categories:

  1. Current Manufacturers: Manufacturers of N95 masks, viral swabs, gloves, face masks, hand sanitizer, ventilators, medical devices, and isolation gowns
  2. Relevant Expertise: companies that have expertise that is relevant to medical machinery and supply. These could include cleanroom manufacturing, fine metal tooling, etc.
  3. Research and Biotech: Manufacturers with expertise and facilities that can be used for testing, and or development of other research-related responses.
  4. Ancillary Support: Companies who can support the companies ramping up medical equipment production by adding to their supply chain or even with temporary labour support.

Thank you for your support. We hope to work with governments at all levels to address these medical supply issues.


CME wants to help manufacturers support Canada’s response. We will assist businesses to connect businesses with goevrnement.

The federal government plan’s announced Friday March 20, 2020 aims to build domestic capacity, generate innovative solutions, and ease the procurement of essential supplies. It will:

  • Build the industrial capability needed to manufacture critical supplies at scale in Canada. This will be done either by re-tooling the manufacturing lines of existing Canadian businesses or rapidly scaling up the production of others that already produce these products.
  • Refocus Canada’s existing industrial and innovation programs, by adding to their mandate a requirement that they prioritize the fight against COVID-19. This includes:
    • the Strategic Innovation Fund to deliver direct support to Canadian companies for large-scale projects
    • National Research Council of Canada to expedite research and development with small and medium-sized enterprises
    • Innovation Superclusters to tap into a national network of 1,800 members, and Innovative Solutions Canada to help companies commercialize products more quickly
  • Deliver direct support to key Canadian companies that are working on large-scale and later-stage research and development projects aimed, in the immediate term, at producing countermeasures to COVID-19.
  • Challenge innovative companies to develop research-based solutions, technologies, and products that can address a variety of COVID-19 issues.
  • Source equipment needed to support Canada’s response to COVID-19 here in Canada. The Government of Canada will use existing supply arrangements and innovative, flexible procurement approaches. It is also reaching out to suppliers to identify and purchase equipment, supplies, and services needed for Canada’s response to COVID-19. With a view to longer-term support, the Government of Canada will ensure procurement flexibility to support innovation and build domestic manufacturing capacity to supply critical health supplies to Canadians.

More details to come…